During the past decade, Legacy Clinic Northwest conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Legacy Clinic Northwest" are "Pulmonary Hypertension" (2 trials). Many other conditions were trialed in "Legacy Clinic Northwest" in a lesser frequency.

Most popular intervention types in "Legacy Clinic Northwest" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Oral treprostinil (UT-15C) Sustained Release Tablets" (1 trials) and "Oral treprostinil (UT-15C) sustained release tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Legacy Clinic Northwest" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Legacy Clinic Northwest". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Legacy Clinic Northwest, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Legacy Clinic Northwest, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".